0001022183-19-000011.txt : 20190809 0001022183-19-000011.hdr.sgml : 20190809 20190809114614 ACCESSION NUMBER: 0001022183-19-000011 CONFORMED SUBMISSION TYPE: 1-A-W PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190809 DATE AS OF CHANGE: 20190809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CB SCIENTIFIC, INC. CENTRAL INDEX KEY: 0001022183 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931216387 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 1-A-W SEC ACT: 1933 Act SEC FILE NUMBER: 024-10954 FILM NUMBER: 191012000 BUSINESS ADDRESS: STREET 1: 10901 ROOSEVELT BLVD STREET 2: 1000 CITY: SAINT PETERSBURG STATE: FL ZIP: 33716 BUSINESS PHONE: 7274179338 MAIL ADDRESS: STREET 1: 10901 ROOSEVELT BLVD STREET 2: 1000 CITY: SAINT PETERSBURG STATE: FL ZIP: 33716 FORMER COMPANY: FORMER CONFORMED NAME: NET X AMERICA INC DATE OF NAME CHANGE: 20000627 1-A-W 1 withraw.rega.htm 1-A-W

 

 

 

 

VIA EDGARAugust 8, 2019 

 

Kristin Lochhead
Office of Electronics and Machinery
Securities and Exchange Commission
Division of Corporation Finance
100 F St, N.E.
Washington, DC 20549

 

Re: Withdrawal of Offering Statement on Form 1-A (File No. 024-10954)

 

To Whom It May Concern:

 

Pursuant to Rule 259 of Regulation A promulgated pursuant to the Securities Act of 1933, as amended, CB Scientific, Inc. (the “Company”) respectfully requests the withdrawal of its Offering Statement on Form 1-A (File No. 024-10954), together with all amendments and exhibits thereto (collectively, the “Offering Statement”), publicly filed with the Securities and Exchange Commission (the “Commission”) on March 5, 2019. The Offering Statement relates to the public offering of shares of the Company’s common stock.

 

The Company is requesting the consent of the Commission to the withdrawal of the Offering Statement because the Company has determined that the consummation of the public offering of its common stock cannot be completed at this time because of serious deficiencies of its Offering Statement on Form 1-A (File No. 024-10954). No shares of common stock have been sold. We will consider filing a new offering statement on Form 1-A to correct the deficiencies.

 

Accordingly, the Company respectfully requests that the Commission issue an order granting the withdrawal of the Offering Statement effective as of the date hereof or at the earliest practicable date hereafter.

 

 Sincerely,

 

/s/ John Verghese

 

John Verghese
Chief Executive Officer

CB Scientific, Inc.

 

 

cc:Craig A. Huffman, Esq.